Literature DB >> 19635604

Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer.

Marc D Tischkowitz, Nelly Sabbaghian, Nancy Hamel, Ayelet Borgida, Chaim Rosner, Nassim Taherian, Archana Srivastava, Spring Holter, Heidi Rothenmund, Parviz Ghadirian, William D Foulkes, Steven Gallinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19635604      PMCID： PMC3914669          DOI： 10.1053/j.gastro.2009.06.055

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  10 in total

1.  Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.

Authors:  Bing Xia; Josephine C Dorsman; Najim Ameziane; Yne de Vries; Martin A Rooimans; Qing Sheng; Gerard Pals; Abdellatif Errami; Eliane Gluckman; Julian Llera; Weidong Wang; David M Livingston; Hans Joenje; Johan P de Winter
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

2.  Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.

Authors:  Bing Xia; Qing Sheng; Koji Nakanishi; Akihiro Ohashi; Jianmin Wu; Nicole Christ; Xinggang Liu; Maria Jasin; Fergus J Couch; David M Livingston
Journal:  Mol Cell       Date:  2006-06-23       Impact factor: 17.970

Review 3.  High-resolution DNA melting analysis: advancements and limitations.

Authors:  Carl T Wittwer
Journal:  Hum Mutat       Date:  2009-06       Impact factor: 4.878

4.  Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer.

Authors:  Najim Ameziane; Ans M W van den Ouweland; Muriel A Adank; Raymond N C P Vijzelaar; Abdellatif Errami; Josephine C Dorsman; Hans Joenje; Hanne Meijers-Heijboer; Quinten Waisfisz
Journal:  Breast Cancer Res Treat       Date:  2009-06-06       Impact factor: 4.872

5.  Penetrance analysis of the PALB2 c.1592delT founder mutation.

Authors:  Hannele Erkko; James G Dowty; Jenni Nikkilä; Kirsi Syrjäkoski; Arto Mannermaa; Katri Pylkäs; Melissa C Southey; Kaija Holli; Anne Kallioniemi; Arja Jukkola-Vuorinen; Vesa Kataja; Veli-Matti Kosma; Bing Xia; David M Livingston; Robert Winqvist; John L Hopper
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

6.  Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.

Authors:  Siân Jones; Ralph H Hruban; Mihoko Kamiyama; Michael Borges; Xiaosong Zhang; D Williams Parsons; Jimmy Cheng-Ho Lin; Emily Palmisano; Kieran Brune; Elizabeth M Jaffee; Christine A Iacobuzio-Donahue; Anirban Maitra; Giovanni Parmigiani; Scott E Kern; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; James R Eshleman; Michael Goggins; Alison P Klein
Journal:  Science       Date:  2009-03-05       Impact factor: 47.728

Review 7.  Familial pancreatic cancer.

Authors:  Chanjuan Shi; Ralph H Hruban; Alison P Klein
Journal:  Arch Pathol Lab Med       Date:  2009-03       Impact factor: 5.534

8.  Association of common PALB2 polymorphisms with breast cancer risk: a case-control study.

Authors:  Peizhan Chen; Jie Liang; Zhanwei Wang; Xiaoyi Zhou; Lu Chen; Mian Li; Dong Xie; Zhibin Hu; Hongbing Shen; Hui Wang
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

9.  Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.

Authors:  María J García; Victoria Fernández; Ana Osorio; Alicia Barroso; Gemma Llort; Conxi Lázaro; Ignacio Blanco; Trinidad Caldés; Miguel de la Hoya; Teresa Ramón Y Cajal; Carmen Alonso; María-Isabel Tejada; Carlos San Román; Luis Robles-Díaz; Miguel Urioste; Javier Benítez
Journal:  Breast Cancer Res Treat       Date:  2008-02-27       Impact factor: 4.872

10.  Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women.

Authors:  William D Foulkes; Parviz Ghadirian; Mohammed Reza Akbari; Nancy Hamel; Sylvie Giroux; Nelly Sabbaghian; Andrew Darnel; Robert Royer; Aletta Poll; Eve Fafard; André Robidoux; Ginette Martin; Tarek A Bismar; Marc Tischkowitz; Francois Rousseau; Steven A Narod
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466
  10 in total
  66 in total

1.  Genetic susceptibility to pancreatic cancer.

Authors:  Alison P Klein
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated.

Authors:  Femme Harinck; Irma Kluijt; Saskia E van Mil; Quinten Waisfisz; Theo A M van Os; Cora M Aalfs; Anja Wagner; Maran Olderode-Berends; Rolf H Sijmons; Ernst J Kuipers; Jan-Werner Poley; Paul Fockens; Marco J Bruno
Journal:  Eur J Hum Genet       Date:  2011-12-14       Impact factor: 4.246

3.  Novel germline PALB2 truncating mutations in African American breast cancer patients.

Authors:  Yonglan Zheng; Jing Zhang; Qun Niu; Dezheng Huo; Olufunmilayo I Olopade
Journal:  Cancer       Date:  2011-08-26       Impact factor: 6.860

Review 4.  Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

Authors:  Andrew D Rhim; Ben Z Stanger
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

5.  Genome-wide somatic copy number alterations in low-grade PanINs and IPMNs from individuals with a family history of pancreatic cancer.

Authors:  Seung-Mo Hong; Audrey Vincent; Mitsuro Kanda; Julie Leclerc; Noriyuki Omura; Michael Borges; Alison P Klein; Marcia Irene Canto; Ralph H Hruban; Michael Goggins
Journal:  Clin Cancer Res       Date:  2012-06-21       Impact factor: 12.531

6.  Targeting reactive nitrogen species suppresses hereditary pancreatic cancer.

Authors:  Mo Li; Qian Chen; Teng Ma; Xiaochun Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

Review 7.  Inherited pancreatic cancer.

Authors:  Fei Chen; Nicholas J Roberts; Alison P Klein
Journal:  Chin Clin Oncol       Date:  2017-12

8.  Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family.

Authors:  Ciyu Yang; Angela G Arnold; Magan Trottier; Yukio Sonoda; Nadeem R Abu-Rustum; Oliver Zivanovic; Mark E Robson; Zsofia K Stadler; Michael F Walsh; David M Hyman; Kenneth Offit; Liying Zhang
Journal:  Breast Cancer Res Treat       Date:  2016-10-18       Impact factor: 4.872

Review 9.  Identifying people at a high risk of developing pancreatic cancer.

Authors:  Alison P Klein
Journal:  Nat Rev Cancer       Date:  2012-12-06       Impact factor: 60.716

Review 10.  Risk of pancreatic cancer in breast cancer families from the breast cancer family registry.

Authors:  Evelina Mocci; Roger L Milne; Elena Yuste Méndez-Villamil; John L Hopper; Esther M John; Irene L Andrulis; Wendy K Chung; Mary Daly; Saundra S Buys; Nuria Malats; David E Goldgar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-01       Impact factor: 4.254
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.